HTLV-I antibody screening in donated blood and thalassemic patients.
The HTLV-I antibody screening by passive partial agglutination test, Serodia HTLV-I (Fuji-rebio Inc) was performed in a total of 1,225 male and 468 female blood donors from September 1992 to March 1993. In addition, a total of 64 multitransfused thalassemic patients were also studied. All of the sera from donors and patients in both study groups showed no reactive results for HTLV-I antibody. This finding indicated that the HTLV-I infection is not yet a problem in blood transfusion in Thailand. However, the scattered reports of HTLV-I infections from our region should urge the national authority on the surveillance of this infection by epidemiological survey and occasional screening in blood donors.
Chiewsilp
P
P
Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Iamsilp
W
W
Hathirat
P
P
D000914:Antibodies, Viral / Q000032:analysis*; D001782:Blood Donors; D001803:Blood Transfusion; D002353:Carrier State / Q000821:virology*; D005260:Female; D015490:HTLV-I Infections / Q000276:immunology / Q000635:transmission*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D008297:Male; D013785:Thailand; D013789:Thalassemia / Q000628:therapy* / Q000821:virology
D000914:Antibodies, Viral